NEWTOWN, PA — Micro Interventional Devices (MID) announced that the U.S. Food and Drug Administration (FDA) has granted ...
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...
Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Study Overview: Edwards Lifesciences Corp. is conducting a ...
The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...